Detailed View
IRWD - Ironwood Pharmaceuticals, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
674,179,008
Adj EBIT (TTM)
248,493,000
Enterprise Value
595,052,008
Last Price
4.08
Earnings Yield
41.76%
Return on Capital
99.14%
Capital
250,641,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 113,041,000 | 79,307,000 |
| 2026-03-31 | 10-Q | 2026 | 106,506,000 | 72,573,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 47,709,000 | 6,805,000 |
| 2025-09-30 | 10-Q | 2025 | 122,060,000 | 75,484,000 |
| 2025-06-30 | 10-Q | 2025 | 85,239,000 | 45,321,000 |
| 2025-03-31 | 10-Q | 2025 | 41,143,000 | -29,108,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 90,545,000 | 31,491,000 |
| 2024-09-30 | 10-Q | 2024 | 91,592,000 | 25,636,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.